N., & Cotter, T
As the global population ages, the prevalence of cognitive dysfunction is increasing worldwide, highlighting the urgent need for effective therapeutic and preventive strategies ( This review aims to provide a thorough and critical assessment of the current understanding of semaglutides role in cognitive dysfunction
Tripeptide DT-109 (Gly-Gly-Leu) attenuates atherosclerosis and vascular calcification in nonhuman primates
Large study shows benefits and harms of GLP-1s in people with diabetes January 27, 2025 Source: Xie, et al, Nature Medicine, January 20, 2025 Researchers published a comprehensive review of electronic medical records from the Veterans Administration (VA) to demonstrate the benefits and harms of GLP-1 medications
Joshua SC Wong, MB, BS, FHKAM (Paediatrics) 2 Jaime Chung, MB, BS 2
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: characteristics and regulation